Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2025-12-24 @ 5:04 PM
NCT ID: NCT06118450
Eligibility Criteria: Inclusion Criteria: * Aged between 18 and 80, regardless of gender; * Initially diagnosed as STEMI and underwent primary PCI; * Voluntarily participated in this trial and signed the informed consent form. Exclusion Criteria: * Coronary angiography shows that PCI is not suitable; * Past history of coronary artery bypass grafting (CABG); * Past history of heart failure; * Past history of myocardial infarction; * Primary or secondary cardiomyopathy or heart valve disease; * Patients with renal insufficiency (eGFR\<30ml/min (1.73m\^2)) or patients undergoing dialysis; * Cardiogenic shock * Persistent left or right coronary ostium lesion after target vessel PCI; * Immediate effect of target vessel PCI is unsatisfactory \[such as thrombolysis in myocardial infarction (TIMI) flow \< grade 2, dissection that restricted blood flow, side branch occlusion (diameter\>1.5mm), exist distal embolism or angiographically visible thrombus\]; * Target vessel exist coronary fistula or myocardial bridge (lumen constriction \>50%); * The target vessel cannot clearly expose the lesion in two positions with an included angle ≥ 30 degrees; * Severe systemic infection * Patients with malignant wasting disease, with an estimated survival of less than 1 year; * The subject is participating in another clinical researches, and the primary endpoint has not been reached; * The investigator believes that the subject has other conditions that are not suitable for clinical trials.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT06118450
Study Brief:
Protocol Section: NCT06118450